OM202JP Clinical Study of KNP2002
The goal of this clinical trial is to evaluate safety and efficacy of KNP2002 in patients with common warts aged 15 to 50 years old.
Common Wart
DRUG: KNP2002|DRUG: Placebo of KNP2002
Change in wart area, Percent change in wart area from baseline, At 16 weeks after starting administration
Change in wart area over time, Percent change in wart area from baseline, At 4, 8, 12, and 16 weeks after starting administration|Wart improvement rate, Wart improvement rate categorized by rate of change in wart area, At 4, 8, 12, and 16 weeks after starting administration|Wart disappearance rate, Proportion of patients with warts disappearing, Up to 16 weeks after starting administration
The goal of this clinical trial is to evaluate safety and efficacy of KNP2002 in patients with common warts aged 15 to 50 years old.